Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topcon 3D OCT-1 Maestro Agreement and Precision Study II

NCT02376868 is registered in ClinicalTrials.gov with Topcon Medical Systems, Inc. as lead sponsor.

NCT NCT02376868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topcon 3D OCT-1 Maestro Agreement and Precision Study II
Lead sponsor
Topcon Medical Systems, Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
September 30, 2015
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eyes with retinal diseases, glaucomatous eyes, normal healthy subjects with no known ocular diseases